Novomics Co., Ltd.
Novomics is a biomedical science company focusing on molecular diagnostic techniques and assays for various cancers. Our products, nProfiler® 1 Stomach Cancer Assay: molecular diagnostic kit for prognosis prediction of GC and nProfiler® 2 Cancer Variant Assay: companion diagnostic kit for solid cancers, will be commercialized in Korea, China, and Southeast Asia and now we are developing an AI-based Spatial Image Analysis platform for breast and colorectal cancer. Learn more at www.novomics.com.